New Tuberculostatic Agents Targeting Nucleic Acid Biosynthesis: Drug Design using QSAR Approaches

E-ISSN： 1873-4286|20|27|4474-4485

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.20, Iss.27, 2014-08, pp. : 4474-4485

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nucleic Acid Drug Delivery and Targeting

By Takakura Yoshinobu

Pharmaceutical Research, Vol. 28, Iss. 4, 2011-04 ,pp. : 691-693

Springer Publishing Company

Access to resources Recommend Favorite

Design of Novel Chemotherapeutic Agents Targeting Checkpoint Kinase 1 Using 3D-QSAR Modeling and Molecular Docking Methods

Current Computer - Aided Drug Design, Vol. 12, Iss. 4, 2016-12 ,pp. : 302-313

Bentham Science Publishers

Access to resources Recommend Favorite

Nonlinear SVM Approaches to QSPR/QSAR Studies and Drug Design

Current Computer - Aided Drug Design, Vol. 3, Iss. 4, 2007-12 ,pp. : 263-289

Bentham Science Publishers

Access to resources Recommend Favorite

Computer-Aided Structure Based Drug Design Approaches for the Discovery of New Anti-CHIKV Agents

Current Computer - Aided Drug Design, Vol. 13, Iss. 4, 2017-11 ,pp. : 346-361

Bentham Science Publishers

Access to resources Recommend Favorite

New Approaches to Target the Mycolic Acid Biosynthesis Pathway for the Development of Tuberculosis Therapeutics

Current Pharmaceutical Design, Vol. 20, Iss. 27, 2014-01 ,pp. : 4357-4378

Bentham Science Publishers

Access to resources Recommend Favorite